Safecor Recalls Acetaminophen, Calcium Vitamin Following GMP Citations
This article was originally published in The Pink Sheet
Executive Summary
Safecor Health's recalls, recently categorized as class II by FDA, began in July 2016, a month after FDA's Office of Regulatory Affairs cited GMP problems at the firm's Columbus, Ohio, facility.
You may also be interested in...
Recent FDA Health And Wellness Product Recalls
Recalls reported by FDA for health and wellness products.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.